Big Money Sentiment About Baxter International Inc (NYSE:BAX) Crashed to 0.66

June 27, 2018 - By Heather Owens

Baxter International Inc. (NYSE:BAX) Corporate Logo

“Big money” Positions

In 2018 Q1 Baxter International Inc (NYSE:BAX) big money sentiment decreased to 0.66, revealed SEC filings. That’s down -0.31, from 2017Q4’s 0.97. 272 active investment managers started new or increased holdings, while 411 sold and decreased their stakes in Baxter International Inc so the sentiment dropped. These funds own 432.17 million shares, that’s down from 441.20 million shares in 2017Q4. Funds holding Baxter International Inc in top 10 changed to 11 from 9 for an increase of 2. In total 43 funds closed positions, 368 reduced and 191 increased. Also 81 funds bought new Baxter International Inc stakes.

Biggest Baxter International Inc Shareholders

As of 2018 Q1 Third Point Llc has 17.58% invested in Baxter International Inc. Baxter International Inc’s shareholder Sector Gamma As owns 715,438 shares as of 2018 Q1. Veritas Asset Management Llp reported 9.54 million shares. The New York-based fund Healthcor Management L.P. have invested about 4.7% of the institutional investor’s stock portfolio in Baxter International Inc. The New York-based fund 13D Management Llc holds 200,318 shares or 3.61% of their fund’s portfolio.

Baxter International Inc. provides a portfolio of renal and hospital products.The firm is worth $39.17 billion. The firm operates through two divisions, Hospital Products and Renal.48.83 is the P/E ratio. The Hospital Products segment makes intravenous solutions and administration sets, premixed drugs and drug-reconstitution systems, pre-filled vials and syringes for injectable drugs, IV nutrition products, parenteral nutrition therapies, infusion pumps, inhalation anesthetics, and biosurgery products.

BAX reached $73.14 during the last trading session after $0.44 change.Baxter International Inc. has volume of 2.12 million shares. Since June 27, 2017 BAX has risen 22.64% and is uptrending. The stock outperformed the S&P500 by 10.07%.

Baxter International Inc. (NYSE:BAX)’s quarterly earnings will be reported on July, 25., according to Faxor. Analysts expect change of 12.70 % or $0.08 from previous year’s $0.63 EPS compared to current’s $0.71 EPS. BAX’s profit could be $380.22 million with 25.75 P/E in case $0.71 EPS is reported. Wall Street now predicts 1.43 % EPS growth despite Baxter International Inc. last quarter’s EPS of $0.70.

Advisors Asset Mgmt Inc reported 10,926 shs stake. Seaward Mngmt Lp stated it has 48,878 shs. M&R Cap accumulated 14,829 shs. 666 were reported by Adirondack. Moreover, Fincl Counselors Incorporated has 0.37% invested in Baxter International Inc. (NYSE:BAX) for 120,440 shs. Carroll Fincl Assocs has invested 0.16% in Baxter International Inc. (NYSE:BAX). Bp Public Ltd Co has 99,000 shs. Lmr Partners Ltd Liability Partnership has invested 0.19% in Baxter International Inc. (NYSE:BAX). Connors Investor Serv invested 0.04% in Baxter International Inc. (NYSE:BAX). Stifel Corporation owns 667,681 shs. Cubist Systematic Strategies Ltd Llc reported 72,316 shs or 0.28% of all its holdings. Lowe Brockenbrough And Incorporated holds 3,315 shs. Hudock Group Ltd Llc reported 1,732 shs. Mitsubishi Ufj And Bk reported 0.14% stake. Comerica Bankshares holds 0.08% or 177,466 shs.

Baxter International Inc. registered $11.07 million net activity with 0 insider purchases and 9 sales since March 2, 2018. On Monday, April 2 HELLMAN PETER S sold $243,408 worth of Baxter International Inc. (NYSE:BAX). Shares for $329,590 were sold by Shapazian Carole J. $1.41M worth of stock was sold by Eyre Brik V on Tuesday, May 15. Shares for $1.21 million were sold by GAVIN JAMES R III. On Wednesday, March 28 $3.10 million worth of stock was sold by STORM KORNELIS J.. $243,443 worth of stock was sold by STROUCKEN ALBERT P L on Monday, April 2.

Baxter International Inc. (NYSE:BAX) Ratings Coverage

In total 13 analysts cover Baxter International (NYSE:BAX). “Buy” rating has 8, “Sell” are 0, while 5 are “Hold”. 62% are bullish. With $83 highest and $70 lowest price target Baxter International has $75.90 average price target or 3.77% above the current ($73.14) price. 16 are the (NYSE:BAX)’s analyst reports since January 2, 2018 according to StockzIntelligence Inc. On Thursday, May 17 the stock of Baxter International Inc. (NYSE:BAX) earned “Buy” rating by Piper Jaffray. In Thursday, February 1 report Cowen & Co maintained the stock with “Hold” rating. On Monday, April 30 the rating was maintained by Stifel Nicolaus with “Hold”. On Monday, April 30 the firm has “Neutral” rating by Citigroup given. The company rating was maintained by RBC Capital Markets on Thursday, February 1. On Wednesday, January 3 the stock has “Outperform” rating by Raymond James. On Tuesday, February 6 the firm earned “Neutral” rating by Citigroup. On Friday, February 2 Barclays Capital maintained Baxter International Inc. (NYSE:BAX) with “Overweight” rating. On Tuesday, May 22 the firm has “Buy” rating given by Bank of America. On Tuesday, January 2 Bank of America upgraded the shares of BAX in report to “Buy” rating.

There’s a significant Baxter International Inc. (NYSE:BAX) news published by Seekingalpha.com. It’s an item titled: “Caladrius Biosciences Strikes Gold With Acquisition Of Late-Stage Refractory Angina Therapy From Shire” on June 26, 2018.

Baxter International Inc. (NYSE:BAX) Institutional Investors Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.